ABSTRACT
The term 'hybrid coronary procedures' refers to a combination of procedures which brings together treatments traditionally available only in the operating room with those offered in the cardiac catheterisation laboratory to offer patients the benefits of all available technology. Hybrid coronary revascularisation (HCR) is a treatment strategy for coronary artery disease (CAD), which offers an alternative to either traditional coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) alone, with the goal being to completely re-vascularise the patient although reducing risk and maximising the benefits of the procedure. The traditional options for coronary reperfusion mainly centred around standard CABG with a median sternotomy and use of a variety of different vessel conduits to bypass multiple coronary arteries at once or the use over PCI and implantation of either a bare metal or drug-eluting stents (DES). Despite evidence suggesting an overall benefit in terms of mortality, these procedures are still only performed in a few centres.
